STARVANIP Trademark
Serial Number: 79276524 • Registration: 6177216
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
Jori R. Fuller McDonnell Boehnen Hulbert & Berghoff LLP
300 South Wacker Drive
Chicago, IL 60606
UNITED STATES
Trademark Details
Filing Date
November 29, 2019
Registration Date
October 20, 2020
Published for Opposition
August 4, 2020
Goods & Services
Pharmaceutical agents affecting sensory organs; pharmaceutical preparations for the treatment of cerebral apoplexy; pharmaceutical agents affecting metabolism; pharmaceutical agents affecting peripheral nervous system; immunomodulators; anti-inflammatories; pharmaceutical agents affecting digestive organs; cardiovascular pharmaceutical preparations; pharmaceutical preparations for the treatment of deep vein thrombosis; drugs for medical purposes, namely, drugs for the treatment of cerebral apoplexy, drugs for affecting metabolism, drugs for affecting the peripheral nervous system, anti-inflammatory drugs, immunomodulatory drugs, cardiovascular drugs, drugs for treatment of deep vein thrombosis, drugs for treatment of systemic emboliform, drugs for treatment of venous thromboembolism, drugs affecting the central nervous system, drugs for treatment of pulmonary embolism, antibiotic drugs, drugs for the treatment of cancer, and drugs effecting respiratory organs; medicines for human purposes, namely, medicines for the treatment of cerebral apoplexy, medicines for affecting metabolism, medicines for affecting the peripheral nervous system, anti-inflammatory medicines, immunomodulatory medicines, cardiovascular medicines, medicines for treatment of deep vein thrombosis, medicines for treatment of systemic emboliform, medicines for treatment of venous thromboembolism, medicines affecting the central nervous system, medicines for treatment of pulmonary embolism, antibiotic medicines, medicines for the treatment of cancer or resistant cancer, and medicines effecting respiratory organs; pharmaceutical preparations for the treatment of systemic emboliform; pharmaceutical preparations for the treatment of venous thromboembolism; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for the treatment of pulmonary emboliform; antibiotics; anti-cancer preparations; pharmaceutical preparations for respiratory organs